Malabre Richard C (CIK 2007730) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-04). Recent activity: Sell AKBA (13,382 shares), Sell AKBA (36,142 shares), Buy AKBA (79,000 shares), Buy AKBA (15,000 shares), Sell AKBA (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Sell | 13,382 | $18,601 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Sell | 36,142 | $50,237 |
| 2026-02-03 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Buy | 79,000 | $0 |
| 2025-06-11 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Buy | 15,000 | $25,200 |
| 2025-06-11 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Sell | 15,000 | $60,150 |
| 2025-06-05 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Sell | 13,334 | $47,069 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Buy | 85,000 | $0 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Accounting Officer | Sell | 30,202 | $63,424 |
Source: SEC Form 4 filings · as of 2026-02-04